Pre-transplantation iron chelation in patients with MDS or acute leukemia and iron overload undergoing myeloablative allo-SCT.
(90)Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphoma.
Bone Marrow Transplant., Dec;46(12):1503-9 (2011)
A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome.
Ann. Oncol., Jul;22(7):1608-13 (2011)
Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies.
Bone Marrow Transplant., Feb;41(3):229-37 (2008)
Outcome of allo-SCT for women with MDS or AML occurring after breast cancer therapy.
Bone Marrow Transplant., Nov;45(11):1611-7 (2010)
Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancy.
Bone Marrow Transplant., Aug;40(3):209-17 (2007)
Quality of life associated with acute and chronic graft-versus-host disease.
Bone Marrow Transplant., Aug;38(4):305-10 (2006)
HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation.
Bone Marrow Transplant., May;37(9):845-50 (2006)
Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease.
Bone Marrow Transplant., Dec;34(11):987-94 (2004)
The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation.
Blood., Dec;98(12):3192-204 (2001)
Effects of transition metals on the expression of the erythropoietin gene: further evidence that the oxygen sensor is a heme protein.
Biochem. Biophys. Res. Commun., Jun;223(1):175-80 (1996)
Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation.
Biol. Blood Marrow Transplant., 7(4):223-9 (2001)
Routine screening for psychosocial distress following hematopoietic stem cell transplantation.
Bone Marrow Transplant., Jan;35(1):77-83 (2005)